Biotech and Pharmaceuticals

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Business

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Novo Nordisk is looking for deals more than ever before, the CEO of the Danish drugmaker said in an interview with CNBC on Wednesday. “If our ambition is to help hundreds of millions of patients out there, then we need not just the best, but the broadest pipeline in the world,” said Novo Nordisk CEO […]

Read More
Wearable patches: How Barrière is trying to disrupt the supplement industry
Business

Wearable patches: How Barrière is trying to disrupt the supplement industry

The supplement industry has seen booming demand over the past few years as consumers increasingly focus on health and wellness. Along with that, wearable patches have become more mainstream, with brands like The What Supp Co and The Good Patch marketing products that they say deliver the same results as oral vitamins without having to […]

Read More
CVS blows past estimates, hikes outlook as insurance business outperforms 
World

CVS blows past estimates, hikes outlook as insurance business outperforms 

A screen displays the logo and trading information for CVS at the New York Stock Exchange, March 24, 2026. Jeenah Moon | Reuters CVS Health on Wednesday blew past first-quarter earnings and revenue estimates and raised its 2026 guidance, as its once-troubled insurance business showed improvement.  CVS, which operates the nation’s largest pharmacy chain, sees […]

Read More
Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.
World

Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.

Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales. Source

Read More
Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts
World

Novo Nordisk stock jumps 6% after drugmaker hikes forcast as Wegovy pill sales smash forecasts

People walk past a sign for Novo Nordisk’s annual general meeting at the entrance to the venue in Copenhagen, Denmark, March 26, 2026. Tom Little | Reuters Novo Nordisk hiked its annual profit guidance on Wednesday, as the drugmaker said its Wegovy weight-loss pill performed better than expected in the first three months of the […]

Read More
FDA withdrew studies finding Covid, shingles vaccines were safe 
Business

FDA withdrew studies finding Covid, shingles vaccines were safe 

The FDA blocked the publication of several studies supporting the safety of vaccines against Covid and shingles in recent months, a Health and Human Services Department spokesperson confirmed on Tuesday.  It’s the latest effort by the Trump administration to challenge safe and effective shots in the U.S. and make them harder to access for some […]

Read More
FDA commissioner defends agency’s drug approval decisions after wave of backlash
Business

FDA commissioner defends agency’s drug approval decisions after wave of backlash

Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland, US, on Tuesday, April 28, 2026. Valerie Plesch | Bloomberg | Getty Images U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday […]

Read More
Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth
World

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as its recently launched and acquired products showed growth. Older top-selling drugs, including its blood thinner […]

Read More
Major health insurers show signs of recovery – but a key test looms
Business

Major health insurers show signs of recovery – but a key test looms

Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging start this year — but a crucial test for the sector is still ahead. Solid first-quarter results have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. Companies including UnitedHealth, […]

Read More
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
World

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance

Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight.  LifeMD went from seeing […]

Read More